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Prenatal risk factors and neonatal DNA
methylation in very preterm infants
Marie Camerota1,2* , Stefan Graw3, Todd M. Everson3,4, Elisabeth C. McGowan5, Julie A. Hofheimer6,
T. Michael O’Shea6, Brian S. Carter7, Jennifer B. Helderman8, Jennifer Check8, Charles R. Neal9,
Steven L. Pastyrnak10, Lynne M. Smith11, Lynne M. Dansereau2, Sheri A. DellaGrotta2, Carmen J. Marsit3 and
Barry M. Lester1,2,5

Abstract
Background: Prenatal risk factors are related to poor health and developmental outcomes for infants, potentially via
epigenetic mechanisms. We tested associations between person-centered prenatal risk profiles, cumulative prenatal
risk models, and epigenome-wide DNA methylation (DNAm) in very preterm neonates.
Methods: We studied 542 infants from a multi-center study of infants born < 30 weeks postmenstrual age. We
assessed 24 prenatal risk factors via maternal report and medical record review. Latent class analysis was used to
define prenatal risk profiles. DNAm was quantified from neonatal buccal cells using the Illumina MethylationEPIC
Beadarray.
Results: We identified three latent profiles of women: a group with few risk factors (61%) and groups with elevated
physical (26%) and psychological (13%) risk factors. Neonates born to women in higher risk subgroups had differential
DNAm at 2 CpG sites. Higher cumulative prenatal risk was associated with methylation at 15 CpG sites, 12 of which
were located in genes previously linked to physical and mental health and neurodevelopment.
Conclusion: We observed associations between prenatal risk factors and DNAm in very preterm infants using both
person-centered and cumulative risk approaches. Epigenetics offers a potential biological indicator of prenatal risk
exposure.
Keywords: Prenatal, Methylation, Epigenetics, Epigenome-wide association study (EWAS), Neonatal, Preterm, Buccal
Background
Infants born less than 30 weeks postmenstrual age
(PMA) are at increased risk for adverse health and developmental outcomes. As children, they are at high risk for
experiencing chronic health problems related to brain
injury, including cerebral palsy, autism spectrum disorder, seizures, epilepsy, mental health disorders [1–4] and
developmental delay in motor, language, and cognitive
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domains [1–3, 5–7]. However, there is also marked heterogeneity in outcomes [8–10]. For example, a recent
follow-up study from the Neonatal Research Network
(NRN) cohort of infants born extremely preterm found
that by age 2, one quarter (24%) of children had no neurodevelopmental impairment, and 45% had only suspected or mild impairment [7].
Adverse prenatal conditions contribute to risk of preterm birth, and may also exacerbate the risk of negative
outcomes associated with immaturity and illness in very
preterm children [11]. For example, maternal mood disorders (e.g., depression, anxiety) and medical complications (e.g., pre-eclampsia, pre-pregnancy obesity) during
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pregnancy predict poorer neurobehavioral outcomes in
very preterm neonates [11], which in turn are associated
with longer term impairments [12]. Sociodemographic
risk factors, such as low socioeconomic status, are also
associated with poor developmental outcomes for very
preterm children [13]. While these adverse conditions
arise from unique sources (physical, psychological, and
sociodemographic), they may impact similar biological
systems and could have additive effects on the developing
fetus. Therefore, exposure to a greater number or specific
combinations of risk factors in the prenatal environment
may contribute to the heterogeneous outcomes observed
among preterm children.
One mechanism by which prenatal conditions may
alter child neurodevelopment is via epigenetic processes
[14]. Epigenetics refers to molecular processes that regulate gene expression without altering the underlying
DNA sequence. DNA methylation (DNAm) is the most
commonly studied epigenetic mechanism in humans and
involves addition of a methyl group to a cytosine-phosphate-guanine (CpG) dinucleotide on a strand of DNA.
DNAm plays an important role in regulating gene activity and expression. Additionally, offspring DNAm is sensitive to variations in environmental experience [15–17]
and therefore may provide information about the biological embedding of prenatal conditions [14, 18–20].
Perhaps the most studied of all prenatal risk factors
are those indicative of maternal psychological distress,
including perceived stress and mood disorders [21].
These factors have also been studied in a growing number of candidate gene and epigenome-wide association
studies (EWAS) [22, 23]. While candidate gene studies
show associations between psychological risk factors in
pregnancy and DNAm in genes implicated in offspring
stress response systems [15], more recent EWAS on the
same psychological risk factors have produced mixed
findings [24–31], with differences not easily explained by
study sample size. Therefore, the extent to which psychological risk factors in pregnancy impact offspring DNAm
remains unclear. Physical risk factors (e.g., pre-pregnancy
body mass index [BMI]) have also been investigated in
relation to offspring DNAm and have similarly been
associated with differential neonatal DNAm at a handful
of CpGs [32]. These previous findings should be interpreted in light of several limitations, including the use of
small sample sizes, exclusive use of cord blood for DNA
sampling, and use of convenience or low-risk samples.
Finally, most previous studies have investigated individual risk factors (e.g., depression, obesity) in isolation,
rather than comprehensively assessing multiple facets of
prenatal stress.
In this study, we investigated the relationship between
prenatal risk factors and DNAm using buccal cell
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specimens in a high-risk population: children born very
preterm. In addition, we studied prenatal risk comprehensively using two multiple-risk-factor approaches,
rather than an individual variable approach. We first used
cumulative risk models to investigate the additive burden
of increasing number of risk factors on neonatal DNAm.
Second, we used person-centered models to investigate
the relationship of different types of risk factors with
neonatal DNAm. Person-centered approaches such as
latent class (LCA) and latent profile analysis (LPA) group
individuals with similar co-occurring risk factors or phenotypes into mutually-exclusive groups. Whereas one
previous study investigated cumulative prenatal risk in
association with neonatal DNAm [24], person-centered
models have not yet been used to study the association
between prenatal risk phenotypes and neonatal DNAm.
Therefore, the goals of this study were to examine relations among prenatal risk factors and DNAm in very preterm neonates and to understand whether these relations
differ depending on whether cumulative risk or personcentered models are used. Addressing these goals may
enable us to identify important biological mechanisms
underlying the association between prenatal environmental experiences and child outcomes and will provide
information regarding how best to operationalize prenatal risk factors in future studies of neonatal health.

Methods
Study population

The Neonatal Neurobehavior and Outcomes in
Very Preterm Infants (NOVI) study enrolled infants
born < 30 weeks postmenstrual age (PMA) from nine
NICUs affiliated with six universities from April 2014 to
June 2016. Inclusion criteria included: (a) birth < 30 weeks
PMA; (b) parental ability to read and speak English or
Spanish; and (c) residence within 3 h of the NICU and
follow-up clinic. Infants were excluded for major congenital anomalies [33], NICU death, maternal age < 18 years,
maternal cognitive impairment, or maternal death.
Parents of eligible infants were invited to participate in the study when survival to discharge was determined to be likely by the attending neonatologist. Study
procedures were explained and informed consent was
obtained in accordance with each institution’s review
board. Children were included in this analysis if they
were enrolled in NOVI at birth and had a neonatal buccal swab collected (MPMA = 39.2 weeks). There were 704
infants enrolled in NOVI; of these 651 (92%) had parental consent to obtain buccal swabs. Mothers were interviewed at enrollment to obtain demographic information
(age, education, occupation, race/ethnicity, and marital/
cohabitation status). Information regarding prenatal
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substance use, physical health, and psychological health
were obtained via maternal interview and medical record
review.
Measures
Prenatal risk factors

We assessed 24 prenatal risk factors in four domains:
demographic (5 items), substance use (4 items), physical
health (9 items), and psychological health (6 items). Individual risk factors were assessed via maternal interview
and medical record review.
Demographic risk factors included maternal
age > 35 years, low socioeconomic status (Hollingshead
category 5) [34], maternal education less than a high
school degree, minority race or ethnicity, and no romantic partner. Substance use items included maternal use of
tobacco, alcohol, marijuana, or other illegal substances
(e.g., heroin, cocaine) as noted in her medical record.
Physical health risks included maternal underweight
(BMI < 18.5) and obesity (BMI ≥ 30), calculated from
reported pre-pregnancy height and weight. Gestational
weight gain that exceeded Institute of Medicine guidelines [35] was also determined using calculated BMI
and reported weight gain. Maternal hypertension, preeclampsia, diabetes, HIV/AIDS or other sexually transmitted infection, any other infection, and receipt of
prenatal care were all determined from medical record
review.
Psychological health risks included maternal depression and anxiety and maternal moods and feelings.
Maternal depression during pregnancy was determined
from medical record or maternal report of anti-depressant use, or from maternal report of depression diagnosis, treatment, or counseling during pregnancy. The same
method was used to determine maternal anxiety during
pregnancy. Beyond diagnosed mental health disorders,
maternal moods and feelings during pregnancy were
assessed from four questions asking mothers to indicate
the extent to which (a) their pregnancy was a hard time
in their lives, and the extent to which they felt (b) down,
(c) hopeless, and (d) slow during their pregnancy. Risk
was determined by responses indicating that pregnancy
was a “very hard time” or “one of the worst times” in their
lives, or if mothers indicated they “often” or “always” felt
down, hopeless, or slow [36].
Neonatal DNA methylation (DNAm)

Genomic DNA was extracted from buccal swab samples,
collected near term-equivalent age, using the Isohelix
Buccal Swab system (Boca Scientific), quantified using
the Quibit Fluorometer (Thermo Fisher, Waltham, MA,
USA) and aliquoted into a standardized concentration for
subsequent analyses. DNA samples were plated randomly

Page 3 of 14

across 96-well plates and provided to the Emory University Integrated Genomics Core for bisulfite modification
using the EZ DNA Methylation Kit (Zymo Research,
Irvine, CA), and subsequent assessment of genome-wide
DNAm using the Illumina MethylationEPIC Beadarray
(Illumina, San Diego, CA) following standardized methods based on the manufacturer’s protocol.
Pre-processing of data followed a modified workflow
described elsewhere [37]. Array data were normalized
via Noob normalization [38, 39] and samples with more
than 5% of probes yielding detection p-values > 1.0E-5
or mismatch between reported and predicted sex were
excluded. In addition, one of two duplicated samples
was omitted (retained duplicated sample with smallest
detection p-values). Probes with median detection p-values < 0.05, probes measured on the X or Y chromosome,
probes that had single nucleotide polymorphisms (SNP)
within the binding region or that could cross-hybridize
to other regions of the genome were excluded [40]. Then,
array data were standardized across Type-I and Type-II
probe designs with beta-mixture quantile normalization
[41, 42]. After exclusions, 706,323 probes were available
from 542 samples for this study (83% of 651 with buccal
swab consent; 77% of entire NOVI cohort). These data
are accessible through NCBI Gene Expression Omnibus
(GEO) via accession series GSE128821.
Covariates

DNAm varies by cell type and cellular heterogeneity is a
documented source of confounding in EWAS that make
use of mixed cell samples [43]. A variety of cell-type
deconvolution methods have been developed to estimate
cell type proportions based on cell-type specific DNAm
pattern. We estimated the proportion of epithelial,
fibroblast, and immune cells (e.g., B-cells, natural killers, CD4 + and CD8 + T-cells, monocytes, neutrophils,
eosinophils) in our buccal samples using reference methylomes [44]. As previously shown [45], for 95% of our
buccal samples, 95.7% of the cells were epithelial cells,
with the remainder being immune cells. Given the strong
inverse correlation between epithelial and immune cell
proportions, cellular heterogeneity was adjusted for by
including the proportion of epithelial cells as a covariate
in all statistical models.
In addition to cellular heterogeneity, our EWAS models controlled for child sex, recruitment site, and PMA at
buccal swab. We accounted for potential batch effects by
controlling for sample plate.
Statistical analysis
Prenatal risk classes and index

We first conducted latent class analysis (LCA) to categorize subgroups of women with similar prenatal risk
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factors. LCA is a statistical method for classifying individuals into mutually exclusive groups, or latent classes,
based on their pattern of responses to a set of categorical indicator variables. The method is considered latent
because true group membership is unknown. LCA
employs maximum likelihood estimation. The optimal
number of latent classes is determined using fit statistics
and interpretibility of the models. For these analyses, we
fit LCA models to our 24 observed risk factors and examined solutions ranging from 1 to 4 classes. All models
were run in Mplus 8.4. We used posterior probabilities
from the best fitting LCA model to classify women into
distinct subgroups. We describe the subgroups in terms
of how they differ on the 24 prenatal risk factors.
Next, we created a cumulative prenatal risk index that
measured the total number of risk factors experienced by
mothers. One point was assigned for each of 24 risk factors and a proportion score was created by dividing this
sum by the total number of items mothers responded to.
A proportion was used rather than a sum because of the
possibility of item nonresponse. However, the majority of
mothers (96%) had data for all 24 items.
Epigenome‑wide association study (EWAS)

All EWAS analyses were conducted in R 4.0.2. We used
generalized estimating equations (GEE) that accounted
for the nesting of children within families.
 GEE models

β
were run on logit transformed (log 1−β ) DNAm data

that approximated a Gaussian distribution. For easier
interpretation of significant CpG sites, we present model
coefficients obtained from both transformed and
untransformed (beta-values) data, where the latter can be
interpreted in terms of percent methylation at a given
CpG site. To account for multiple testing, p-values were
adjusted using a Bonferroni correction (α = 0.05/706323).
We conducted separate EWAS analyses with latent prenatal class (3-level factor) and cumulative prenatal risk
(continuous) as the focal independent variables and compare our findings from the two types of models. We
report results from models that yielded suggestive associations (FDR < 10%) in Additional file 1 and report those
results that were significant with Bonferroni-correction
(706,323 tests) herein.
One challenge of EWAS in humans is the inaccessibility of tissues of interest, namely brain tissue. Although
we rely on peripheral tissues such as buccal cells, there
is variability in the extent to which peripheral DNAm is
associated with DNAm in the brain. For CpGs that were
significantly associated with prenatal risk in either latent
class or cumulative risk models, we examined the correlation between DNAm in buccal and brain tissue [46].
This additional information can help us determine which
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of our significant CpGs may have similar patterns of
DNAm in buccal and brain tissue.
To determine the biological functions of CpGs associated with prenatal risk, we conducted gene enrichment
analyses using the gometh function in the MissMethyl
package [47]. This procedure accounts for the number
of CpGs annotated to each gene. We examined both
pathway-based gene sets (i.e., KEGG and gene ontology (GO) terms). For enrichment analyses, we included
CpGs that were associated with prenatal risk at an FDR
of < 5%. Overrepresentation results within a 10% FDR
were deemed statistically significant. We also aimed to
identify whether any CpGs associated with prenatal risk
were within genes that have been linked with neurodevelopmental phenotypes. Thus, based on the genes that
were annotated to our significant CpGs, we additionally
annotated these CpGs with traits that have been linked
to these genes via prior genome-wide association studies
(GWAS) using the NHGRI-EBI GWAS catalog [48].
All analyses described thus far have described methods
for estimating the association between prenatal risk and
individual CpGs. However, DNAm is generally highly
correlated at adjacent CpG sites [49]. To better understand whether our EWAS results are limited to individually significant CpGs or are more broadly representative
of regions of the genome that are differentially methylated, we additionally conducted differentially methylated
regions (DMR) analysis using the dmrff package [50].

Results
Study population

The NOVI study included 704 infants born to 601 mothers. All mothers were included in the LCA analysis. Of
the 651 potential buccal swabs, 624 (96%) were collected.
Missing data were due to technical sampling or handling
error, missing swabs, or unscheduled discharges prior
to swabs being obtained. Of the 624 infants with buccal
swabs, there were 542 infants (from 470 mothers) with
DNAm data that passed quality control steps (described
earlier).
Maternal and child characteristics are summarized in
Table 1. Those without DNAm data were more likely to
be low SES (p = 0.04) and to be a minority race or ethnicity (p = 0.004), compared to those with DNAm data.
Included and excluded children did not differ based
on prenatal risk class or cumulative prenatal risk (all
p > 0.05).
Prenatal risk

We first estimated LCA models and used standard model
fit statistics to determine the ideal number of latent profiles. Lo-Mendell-Rubin and bootstrapped loglikelihood
ratio tests indicated that the 4-profile model did not fit
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Table 1 Demographic and medical characteristics of the sample
Sample characteristics

Full sample
(N = 601)

Included
(N = 470)

Excluded
(N = 131)

p-value

Maternal characteristics*
Maternal education: < HS/GED

13% (79/598)

15% (68/468)

8.5% (11/130)

0.07

Low SES: Hollingshead = 5

9.9% (59/599)

8.5% (40/469)

15% (19/130)

0.04

Minority race or ethnicity±

58% (347/601)

55% (257/470)

69% (90/131)

0.004

No partner

25% (152/600)

26% (124/470)

22% (28/130)

0.26

Neonatal characteristics

Full sample
(N = 704)

Included
(N = 542)

Excluded
(N = 162)

p-value

Infant gender = Male

56% (388/697)

55% (299/539)

56% (89/158)

0.85

Multiple gestation

26% (184/697)

27% (145/539)

25% (39/158)

0.58

Cesarean delivery

71% (495/696)

71% (382/539)

72% (113/157)

0.79

PMA at Birth (weeks)

27.0 ± 1.92

27.0 ± 1.92

27.0 ± 1.92

0.86

24.5 ± 2.43

24.5 ± 2.48

24.4 ± 2.24

0.70

99.7 ± 47.4

0.05

Birth weight (grams)
Head circumference (cm)
PMA at Discharge (weeks)
Length of NICU stay (LOS days)
Weight at discharge (grams)
Severe retinopathy of prematurity

948.3 ± 280.6
40.5 ± 5.43

93.5 ± 41.9

3013 ± 905

5.9% (41/697)

951.1 ± 281.8
40.3 ± 5.20

91.7 ± 40.1

3001 ± 861

6.3% (34/539)

938.5 ± 277.0

0.62

41.29 ± 6.12

0.05

3057 ± 1042

0.50

4.4% (7/158)

0.38
0.35

Necrotizing enterocolitis/sepsis

18% (128/697)

19% (103/539)

16% (25/158)

Chronic lung disease

51% (357/697)

51% (277/539)

51% (80/158)

0.87

Serious brain injury+

13% (92/694)

13% (69/539)

15% (23/155)

0.51

Means ± standard deviations (continuous) or percentage and frequencies (categorical) of demographic and medical characteristics. p-values refer to the comparison
of included versus excluded individuals and were obtained from t-tests (continuous variables) and chi-squared tests (categorical variables)
PMA, postmenstrual age; HS, high school; GED, General Equivalency Diploma; SES, socioeconomic status
*All mothers with prenatal data were included in the latent class analysis. Included versus excluded in this Table refers to individuals with data for the epigenomewide analysis
±

Minority race or ethnicity was defined as any non-White race (e.g., Black, Asian) or ethnicity (e.g., Hispanic and/or Latino/a)

+

Serious brain injury included parenchymal echodensity, periventricular leukomalacia, or ventricular dilation diagnosed via cranial ultrasound

significantly better than the 3-profile model, but that the
3-profile model did fit significantly better than the 2-profile model. The 3-profile solution had the lowest Bayesian
information criterion (BIC), high entropy (0.84), and high
class probabilities (0.89–0.94). The class sizes were reasonable (smallest class = 13%) and the classes were readily interpretable. Thus, model fit statistics supported a
3-profile LCA solution. Fit statistics for all LCA solutions
are included in Additional file 2.
Women in the three latent classes differed on 21 out of
24 prenatal risk factors (Table 2). Figure 1 depicts differences in the 3 classes by rates of endorsement of prenatal
risk factors. Women in class 1 (“Typical”; 61%) had the
lowest rates of endorsement for all risk factors. In contrast, women in class 2 (“Physical Risk”; 26%) exhibited
elevated physical health problems, including high rates
of obesity, hypertension, and pre-eclampsia. Women
in class 3 (“Psychological Risk”; 13%) exhibited elevated
substance use and psychological health problems. They
endorsed high rates of alcohol, tobacco, and drug use
during pregnancy, as well as high rates of anxiety and

depression. Women in class 3 were also more likely to
indicate that they felt “down”, “slow”, and “hopeless” during their pregnancy, and to indicate that their pregnancy
was a “very hard time” in their lives.
We then calculated a cumulative prenatal risk score for
each participant. On average, mothers experienced an
average of 3.6 risk factors (SD = 2.3), with a range from
0 to 12.
Epigenome‑wide association study with prenatal risk
profiles

Our first set of models compared DNAm for children
born to women in the Physical Risk or Psychological
Risk groups to children born to women in the Typical
group. Results are displayed in Table 3. After Bonferroni
adjustment, one CpG was differentially methylated in the
Physical Risk group and one CpG was differentially methylated in the Psychological Risk group. Compared to the
Typical group, neonates of mothers in the Physical Risk
group had, on average, 5% lower DNAm at the identified CpG (cg25123362) located in the body of the BNIP3
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Table 2 Distribution of individual prenatal risk factors in full sample and by latent class
Prenatal risk factors

Full sample
(N = 601)

Typical
(N = 367; 61%)

Physical risk
(N = 155; 26%)

Psychological risk
(N = 79; 13%)

χ2

Age > 35

18%

18%

18%

14%

0.89

Low SES

10%

6.5%

14%

18%

12.78**
12.54**

< HS degree

13%

12%

9.8%

26%

Minority

58%

57%

56%

66%

No partner

25%

21%

18%

62%

65.33***

No prenatal care

2.7%

1.6%

1.9%

9.1%

14.01***

Underweight

5.0%

5.8%

0.0%

12%

15.48***

Obese

34%

26%

53%

33%

35.11***

Too much weight gained

18%

12%

34%

17%

33.93***

Hypertension

27%

3.3%

95%

3.9%

490.33***

Pre-eclampsia

21%

0.0%

79%

0.0%

442.57***

Diabetes

6.0%

5.5%

9.7%

1.3%

7.00*

STI/HIV

7.0%

5.0%

6.5%

18%

16.33***

2.45

Infection

10%

10%

9.0%

14%

Alcohol

3.2%

1.4%

2.6%

13%

27.18***

1.39

Illegal substances

4.5%

0.3%

4.5%

24%

85.30***

Tobacco

14%

8.0%

14%

44%

70.36***

Marijuana

10%

4.1%

8.4%

41%

96.07***

Depression

11%

4.9%

10%

39%

79.51***

Anxiety

12%

7.4%

9.7%

35%

50.62***

Pregnancy “Hard Time”

11%

6.7%

6.5%

42%

86.18***

Pregnancy “Felt Down”

9.9%

2.7%

5.9%

51%

173.87***

Pregnancy “Felt Slow”

20%

13%

23%

46%

44.90***

Pregnancy “Felt Hopeless”

3.9%

0.3%

1.3%

26%

115.30***

STI, sexually transmitted infection; HIV, Human immunodeficiency virus
*p < .05, **p < .01, ***p < .001

gene. Neonates of mothers in the Psychological Risk had
4% lower DNAm at the identified CpG (cg08930413)
located in the body of the PRKAG2 gene.
Epigenome‑wide association study with cumulative
prenatal risk

Next, we tested for associations between cumulative
prenatal risk and neonatal DNAm. We found 15 statistically significant CpGs that were differentially methylated
with increasing cumulative prenatal risk (Fig. 2). Increasing prenatal risk was associated with lower DNAm at 12
CpGs and higher DNAm at 3 CpGs. These differences
were small in magnitude and ranged from a 1–6% difference in DNAm associated with a 10% increase in cumulative prenatal risk.
Brain‑buccal correlations

We used the publicly available IMAGE-CpG website
(http://han-lab.org/methylation/default/imageCpG) to
explore whether DNAm levels in buccal tissue was correlated with DNAm levels in brain tissue [46], for the CpGs

that were identified as significant in our EWAS models.
While neither of the CpGs identified in our prenatal risk
profile EWAS exhibited significant brain-buccal correlations, 4 of the 15 CpGs that were identified in our models
of cumulative prenatal risk did exhibit significant brainbuccal correlations (r = 0.44 to 0.61, p < 0.05).
Functional and phenotypic enrichment

Because few CpGs were significant in our prenatal risk
profile EWAS, we considered in our enrichment analyses those CpGs that were significant within a 5% FDR in
the cumulative prenatal risk model (n = 384 CpGs). After
FDR correction, there were no significantly enriched
pathway or gene ontology terms.
CpG annotation

We identified phenotypes and traits that have been associated with the genes annotated to significant CpGs in
our EWAS models (Table 4). Of the 17 significant CpGs,
9 were located in genes associated with neurobehavioral
traits including cognitive ability, memory, reaction time,
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Fig. 1 Rates of endorsement of 24 prenatal risk factors by latent class membership. Women in class 1 (green; 61%) endorse few prenatal risk factors.
Women in class 2 (red; 26%) endorse elevated physical health problems, whereas women in class 3 (blue; 13%) endorse elevated substance use and
psychological problems

brain volume, and mental health disorders (e.g., depression, bipolar disorder, schizophrenia). Of these 9 CpGs
within neurobehaviorally-linked genes, 3 had significant
blood-buccal correlations (cg19573457 [CRYBB2P1],
cg11221492 [MBIP], cg22102865 [ZNF398]).
Additionally, 11 of the 17 CpGs were located in genes
associated with physical health markers, including body
mass index, cardiovascular disease, hypertension, type-2
diabetes, and white blood cell counts. Of these 11 CpGs
within health-linked genes, 3 had significant blood-buccal correlations (cg16999677 [ZDHHC11], cg11221492
[MBIP], cg22102865 [ZNF398]).
DMR analysis

Last, we performed DMR analyses to test whether there
were regional, not just CpG site-specific, differences in
DNAm associated with prenatal risk factors. DMR analyses comparing the Physical Risk group to the Typical
group found one significant region (Chr10: 133793734–
133794558) containing three CpG sites (cg25123362,
cg12751948, cg16592121). Children born to mothers
in the Physical Risk group had less methylation in this
region, on average, compared to children born to mothers in the Typical group (p = 4.17E-11). This region contained the individually significant CpG described above

in the Physical Risk versus Typical model (cg25123362)
and this DMR similarly annotated to the BNIP3 gene.
Analyses comparing the Psychological Risk group to
the Typical group also resulted in one significant DMR
(Chr14: 77785784–77785968) containing two CpG sites
(cg02181287, cg03738767). Children born to mothers in
the Psychological Risk group had less methylation in this
region, on average, compared to children born to mothers in the Typical group (p = 4.65E-08). This DMR was in
a different genomic location compared to the individually
significant CpG described earlier and annotated to the
GSTZ1 and POMT2 genes.
Finally, we found six DMRs that were significantly
associated with cumulative prenatal risk. Five of the six
were negatively associated with prenatal risk, suggesting
lower DNAm with increasing levels of risk. One DMR
was positively associated, suggesting more DNAm with
increasing levels of risk. One of the six significant DMRs
(Chr7: 148843026–148844053) was in a similar region
as a CpG (cg22102865) that was identified as being
individually significant. One region (Chr14: 77785784–
77785968) that was identified as a DMR related to
cumulative prenatal risk was also identified as a significant DMR in the comparison of the Psychological Risk
group to the Typical group. The other four DMRs (Chr3:
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Table 3 Epigenome-wide association study results for CpG sites that yielded significant associations after Bonferroni adjustment
CpG

Location

Gene annotation

Coefficient p value (Raw) p value (Adj) Coefficienta Brain-buccal
(m-value)
(beta-value) correlation

Model 1: Physical Risk vs.
Typical
cg25123362

Chr10: 133793734 BNIP3 (Body)

− 0.25

2.76E−11

1.95E−05

− 0.05

− 0.09

Chr7: 151548036

PRKAG2 (Body)

− 0.28

2.11E−08

1.49E−02

− 0.04

0.22

cg16999677

Chr5: 843982

ZDHHC11 (Body)

4.84E−02

Chr1: 116994757

LOC101929023 (Body)

− 2.05

6.85E−08

cg05324191

1.03

1.30E−09

9.18E−04

− 0.05

cg01533736

Chr20: 22542854

LINC00261 (Body)

cg00569188

Chr21: 41122530

IGSF5 (Body)

− 1.18

cg09979763

Chr1: 245499904

KIF26B (Body)

cg11420269

Chr16: 70516713

COG4 (Body; ExonBnd)

cg27514986

Chr15: 39486981

C15orf54+

cg05636131

Chr7: 148844053

ZNF398 (5’ UTR; TSS1500)

Model 1: Psychological Risk
vs. Typical
cg08930413
Model 2: Cumulative Prenatal Risk

+

cg11531492

Chr3: 125673505

cg26760502

Chr14: 105493800 CDCA4+

cg19573457

Chr22: 25893657

cg01284858

Chr10: 123902371 TACC2 (5’UTR; Body)

cg12155575

Chr3: 186965150

MASP1 (Body)

cg11221492

Chr14: 36790270

MBIP (TSS1500)

cg22102865

Chr7: 148844067

a

1.17E−09

8.25E−04

− 1.28

4.61E−08

3.26E−02

− 2.02

4.23E−08

2.99E−02

− 1.46

2.07E−08

1.46E−02

2.78

9.74E−09

6.88E−03

− 1.09

6.93E−08

4.90E−02

− 2.63

6.56E−08

4.63E−02

− 0.88

4.89E−08

3.45E−02

− 1.68

2.17E−08

1.53E−02

3.61

6.20E−09

4.38E−03

− 1.16

8.97E−09

6.33E−03

3.92E−08

2.77E−02

ZNF398 (TSS1500; 5’ UTR) − 1.24

1.37E−08

9.64E−03

ROPN1B

CRYBB2P1+

− 0.90

0.02

− 0.03

− 0.03

− 0.03

− 0.03
0.05

− 0.02

− 0.05
− 0.01
− 0.04

0.06

− 0.03

− 0.01

− 0.02

0.61**
− 0.33

0.40

− 0.17

− 0.07

0.02

0.19
0.42‡
− 0.08
− 0.09

0.44*

− 0.32

0.08
0.54*
0.46*

‡

Note that the coefficient for cumulative risk models represents the expected increase in % DNAm associated with a 10% increase in risk. p < .10, *p < .05, **p < .01, +
indicates closest gene. Adjusted p-value is Bonferroni corrected

186965021–186965150; Chr1: 155659719–155659882;
Chr22:
25884154–25884537;
Chr15:
34260712–
34260956) did not share CpGs in common with other
DMR analyses or with the individual CpG results. These
four DMRs annotated to the following genes: MASP1,
DAP3, YY1AP1, CRYBB2P1, AVEN, and CHRM5. Full
results for the DMR analysis are included in Additional
file 3.

Discussion
We conducted an epigenome-wide study to test the
associations between prenatal risk factors and neonatal
DNAm in a sample of very preterm neonates. LCA findings showed 3 distinct prenatal risk groups; a group with
few risk factors (“Typical”; 61%) and groups with elevated
physical (26%) or psychological (13%) risk factors. Neonates born to women in these higher risk subgroups had
differential DNAm patterns at two CpG sites. The cumulative prenatal risk analysis showed that a higher risk
score was associated with greater methylation at 3 CpG
sites and lower DNAm at 12 CpG sites.
The investigation of both the total number (cumulative score) and co-occurring types (LCA profiles)

of prenatal risk factors as they relate to epigenomewide DNAm in infants, including preterm infants,
is novel. Previous EWAS have relied on a single variable approach with mixed findings. Two studies found
no associations between psychological risk factors
and neonatal DNAm [24, 25], several studies uncovered only a small number of differentially methylated
CpGs [26–31], and one study found 145 differentially
methylated CpGs [51]. The only other study using a
cumulative risk approach found no significant associations between cumulative prenatal stress and neonatal DNAm [24]. However, this study measured DNAm
from blood, used a different DNAm bead chip, included
term as well as preterm children, and did not assess
physical health risks. In contrast, the cumulative prenatal risk index used in the current study accounted for
24 demographic, substance use, physical health, and
psychological health indicators. There was no overlap
between significant CpGs or genes identified in this
study and those identified in any of the previous EWAS
on prenatal risk factors. These differences may be due
to differences in methods (e.g., which risk factors were
assessed; single versus multiple risk approach) and
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Fig. 2 Manhattan plot of epigenetic loci associated with cumulative prenatal risk. The x-axis shows the genomic location of individual CpG sites
and the y-axis shows the −log10(p values) from models relating cumulative prenatal risk to CpG methylation, adjusting for child sex, recruitment
site, postmenstrual age at collection, sample batch, and cellular heterogeneity. Gene annotations have been added for all CpGs yielding significant
associations after Bonferroni adjustment. The horizontal red line depicts the Bonferroni adjusted p-value threshold (α = 0.05/706323). +indicates
closest gene

samples (e.g., primarily term versus exclusively preterm
children).
We also investigated the relationship between prenatal
stress phenotypes and neonatal DNAm by using LCA to
classify women into subgroups on the basis of the same
24 risk factors. We found evidence for three distinct prenatal stress phenotypes. The majority of women belonged
to a group that experienced few risk factors. In comparison, women in the physical risk group had elevated levels of medical risk factors, such as hypertension (95%)
and pre-eclampsia (79%). Women in the psychological
risk group had elevated levels of mental health concerns,
including the highest rates of depression (39%) and anxiety (35%), as well as the highest rates of tobacco (44%),
marijuana (41%), alcohol (13%), and illegal drug (24%)
use. Previous work investigating prenatal stress phenotypes in relation to fetal and neonatal behavior [52] also
found a group with elevated physical risk factors (e.g.,
higher blood pressure, greater calorie, fat, and sugar consumption) and a group with elevated psychological risk
factors (e.g., greater depression, anxiety, and perceived

stress) with similar proportions of women falling into
the low risk or typical group (approximately 2/3) versus
one of the two higher risk groups (approximately 1/3).
These similarities emerged despite different study methodologies (e.g., maternal self-reported versus objectively
assessed risk factors) and different variables included in
the latent models. Taken together, these findings provide
evidence for distinct subgroups of women who may differentially be impacted by physical health issues or psychological health issues during pregnancy. However, our
study is the first to demonstrate associations between
prenatal risk phenotypes and neonatal DNAm.
Among the 15 CpGs that were associated with cumulative prenatal risk, 12 were located in genes that have
been linked in GWAS studies to relevant phenotypes
for both physical (e.g., blood pressure [53], BMI [54],
diabetes [55]) and mental health outcomes (e.g., schizophrenia [56], depression [57], bipolar disorder [58]) as
well as neurodevelopmental markers (e.g., brain volume/measurement [59], reaction time [60]). One gene
(CDCA4) identified in our analysis encodes a member
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Table 4 CpGs associated with prenatal risk are linked to genes that have been associated with traits in the GWASdb
Gene

Traits (N) Selected traits

BNIP3

8

Self-reported educational attainment, intelligence, mathematical ability, household income, schizophrenia, cognitive function

PRKAG2

38

Self-reported educational attainment, mathematical ability, brain/neuroimaging measurement, gut microbiome measurement, white matter microstructure, cardiovascular disease, brain volume measurement, bipolar disorder, psychotic
symptoms, cognitive function

ZDHHC11

1

Myopia age of onset

LOC101929023 –

–

LINC00261

4

Body mass index, fasting blood glucose measurement, birth weight

IGSF5

4

Systolic blood pressure, hypertension, short-term memory, health literacy

KIF26B

15

Brain volume/neuroimaging measurement, response to SSRI, unipolar depression, diet measurement, brain measurement,
schizophrenia

COG4

3

Body height, body weight, body mass index

C15orf54

1

Dihydroxy docosatrienoic acid measurement

ZNF398

10

Brain volume/neuroimaging measurement, white blood cell count

ROPN1B

–

–

CDCA4

1

Telomere length

CRYBB2P1

4

Bipolar disorder

TACC2

16

Opioid dependence, metabolite measurement, body weight gain, schizophrenia, body height, reaction time measurement

MASP1

3

Type 2 diabetes

MBIP

6

Self-reported educational attainment, hypertension

of the E2F family of transcription factors, which regulate spindle organization, cytokinesis, and cell proliferation [61]. This gene has also previously been shown
to be associated with leukocyte telomere length [62],
suggesting potential ties between prenatal risk and biological aging processes. There was also some overlap in
genes (KIF26B; TACC2) identified in the current analysis with genes we previously reported to be associated
(FDR < 0.10) with atypical neurodevelopmental profiles in the same sample [45]. Therefore, it is possible
that DNAm of these genes may play a role in explaining the prenatal programming of child neurodevelopment, although additional longitudinal studies would
be needed to rigorously test this hypothesis.
Only 2 CpG sites were differentially methylated
across prenatal risk groups. Neonates of mothers in the
physical risk group had 5% less methylation, on average, at cg25123362, located in the BNIP3 gene. Neonates of mothers in the psychological risk group had
4% less methylation, on average, at cg08930413, located
in the PRKAG2 gene. Interestingly, both the BNIP3
and PRKAG2 genes have been associated with similar
traits in previous GWAS analyses, including educational attainment [63] and cognitive function [60, 63],
suggesting that the associations between prenatal risk
factors and child outcomes may be marked by some
degree of equifinality (i.e., different biological pathways
leading to the same outcome) [64].

Our DMR analyses yielded overlapping results with
the individual CpG analyses for ZNF398 (associated
with cumulative risk) and BNIP3 (associated with physical risk group). We also identified four significant DMRs
that did not include individually significant CpGs from
our EWAS, annotated to MASP1, DAP3, YY1AP1,
CRYBB2P1, AVEN, and CHRM5. ZNF398 and BNIP3 are
particularly interesting given that they were identified in
both CpG-specific and regional analyses. Prior GWAS
have linked ZNF398 to brain volume and neuroimaging
measurements [65], while BNIP3 has been linked to cognitive function [60]. Additionally, we found that DNAm
levels at one CpG within the ZNF398 gene (cg22102865)
were positively correlated between brain and buccal tissues from publicly available data [46].
It was notable that our analysis using cumulative prenatal risk identified more significant CpGs (N = 15) than
our analyses investigating phenotypes of prenatal risk
(N = 2). There was also no overlap in significant CpGs or
genes identified by the two models, suggesting that they
may be unique methods for identifying risk. Cumulative risk models are attractive because of their simplicity, parsimony, and relatively greater statistical power,
compared to alternative approaches (e.g., individual
risk variables) [66]. They also mimic how these factors
impact pregnant women as they rarely occur in isolation. An empirical comparison of cumulative risk indices
to either individual variable or factor score approaches
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also found that risk indices provide better prediction of
developmental patterns [67]. Therefore, cumulative prenatal risk indices may be a useful approach in that they
provide a strong signal for the relationship of early adversity to child outcomes, including DNAm. Indeed, there
is precedence in the epigenetic literature for the use of
cumulative risk scores as predictors of children’s DNAm
[24, 68]. The disadvantages of cumulative risk indices
are that each individual risk factor carries equal weight.
Moreover, we cannot determine which variables are the
most important drivers in explaining the association with
outcomes which limits the practical application of these
risk indices in clinical practice. Alternative “person-centered” approaches, like LCA and LPA models, allow for
the modeling of patterns of correlated risk factors as they
co-occur in real participants. An underlying assumption is that different types of risk are differentially associated with outcomes. “Person-centered” approaches
offer advantages over individual variable or cumulative
risk approaches in that they are both comprehensive and
specific. The differentiation of prenatal risk phenotypes
into physical and psychologically stressed individuals
offer a new way to think about types of adverse prenatal
environments that may be differentially related to child
outcomes [52] and may require different types of intervention. Previous studies comparing cumulative risk and
LPA approaches in the context of child development have
similarly reported that these two types of analyses provide complementary information about the relationships
between risk factors and outcomes [69].
Limitations of this study are to be appreciated. First,
we only considered binary risk factors as opposed to
continuous indicators. This decision was partly necessitated by our creation of a cumulative risk index. Many of
the risk factors we included (e.g., presence or absence of
physical or mental health diagnosis) are dichotomous in
nature but some loss of information may have occurred
from dichotomizing other variables (e.g., SES). Second, as
the inclusion criteria for this study included birth prior
to 30 weeks gestation and likely survival to discharge,
women were necessarily recruited after pregnancy, and
some pregnancy data were assessed retrospectively (e.g.,
maternal report of pregnancy moods and feelings). However, any retrospective data were collected in the neonatal period, potentially reducing the impact of recall bias.
Third, we were unable to locate an external replication
sample because of the unique nature of this cohort (e.g.,
very preterm neonates). The unique nature of the sample means that it is unclear to what extent our results
are sample specific or whether they would generalize to
later preterm or term children. Fourth, we observed differential DNAm in buccal cells rather than in the tissues
that may be more clearly related to children’s health (i.e.,
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neural tissues for neurodevelopment). However, a benefit
of measuring DNAm in peripheral tissue is that it could
represent processes that are occurring elsewhere in the
body such as in the immune and metabolic systems. As
prematurity is a systemic condition impacting nearly all
organ systems, peripheral tissues may be particularly relevant to study in this sample. Finally, although the differences in DNAm we observed were small (1–6%), they are
consistent with what has been reported in other epidemiological studies investigating peripheral DNAm as it
relates to other prenatal risk factors (e.g., smoking [70]),
as well as previous studies in our sample [37, 45]. However, small effects in DNAm are likely important [71], as
they open a potential window into understanding mechanisms driving child health.

Conclusions
In sum, we observed associations between prenatal risk
factors and DNAm in very preterm infants using both
cumulative risk and risk phenotype approaches. Epigenetics offers a potential biological indicator of the
amount and type of prenatal risk that children were
exposed to, which may be particularly useful for identifying infants at greatest risk especially in populations of
vulnerable infants. There remains a need to better understand whether differences in DNAm at birth are related
to children’s health and neurodevelopmental trajectories.
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